In fact, lung CD103− CD69+ T cells of older patients with COVID-19 produce elevated inflammatory molecules associated with worse lung pathology and reduced lung function (232). It has been found that respiratory CD103- CD69+ T cells exacerbate lung pathology and reduce lung function (232). Here, CD69 is linked to COVID-19.